Cantitate/Preț
Produs

Using the Pharmaceutical Literature

Editat de Sharon Srodin
en Limba Engleză Paperback – 5 sep 2019
Gathering information of critical importance for professionals in the pharmaceutical and medical device industries, this guide provides a comprehensive overview of key resources, such as databases, on-line directories, reports, and periodicals-providing at-a-glance guidance and collection development tools for information professionals in this field.

Each chapter corresponds to a key stage or component of the drug development processin a typical pharmaceutical company and covers the types of information typically required at that particular phase.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 51160 lei  6-8 săpt.
  CRC Press – 5 sep 2019 51160 lei  6-8 săpt.
Hardback (1) 141071 lei  6-8 săpt.
  CRC Press – 16 feb 2006 141071 lei  6-8 săpt.

Preț: 51160 lei

Preț vechi: 60188 lei
-15%

Puncte Express: 767

Preț estimativ în valută:
9048 10707$ 7889£

Carte tipărită la comandă

Livrare economică 03-17 aprilie


Specificații

ISBN-13: 9780367391133
ISBN-10: 0367391139
Pagini: 344
Dimensiuni: 152 x 229 x 25 mm
Greutate: 0.54 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press

Public țintă

Academic and Professional Practice & Development

Cuprins

An Introduction to the Drug Research and Development Process. Chemistry. Genomics, Proteomics and Bioinformatics. Toxicology. Pharmacology. Drug Regulation. Sales and Marketing. Competitive Intelligence. Pharmacoeconomics. Intellectual Property. Medical Devices and Combination Products

Descriere

Gathering information of critical importance for professionals in the pharmaceutical and medical device industries, this guide provides a comprehensive overview of key resources, such as databases, on-line directories, reports, and periodicals-providing at-a-glance guidance and collection development tools for information professionals in this field. Each chapter corresponds to a key stage or component of the drug development process and covers the types of information typically required at that particular phase.